See the DrugPatentWatch profile for Crestor
What are Crestor and Lipitor?
Crestor is the brand name for rosuvastatin. Lipitor is the brand name for atorvastatin. Both are statin drugs used to lower LDL (“bad”) cholesterol and reduce cardiovascular risk.
How do they compare for lowering LDL?
Both rosuvastatin (Crestor) and atorvastatin (Lipitor) reduce LDL and are used for similar goals. In practice, rosuvastatin is often chosen when a patient needs a larger LDL reduction at a given dose, while atorvastatin is widely used across many dose ranges. Exact LDL response depends on dose, adherence, diet, baseline cholesterol, and individual response.
Which one is stronger at similar doses?
At equivalent “typical” starting doses, rosuvastatin and atorvastatin can produce different LDL reductions. Clinicians generally select based on the amount of LDL lowering needed and patient-specific factors (such as other conditions and drug interaction risk), then adjust the dose and recheck lipids.
Are the side effects the same for both?
The safety profiles are broadly similar because both are statins. Common concerns include muscle-related side effects (from mild aches to rare serious muscle injury), liver enzyme elevations, and effects on blood sugar risk in some patients. The risk can vary person to person and also depends on dose and other medications.
How do drug interactions differ?
Drug interactions depend on the specific statin and the patient’s other medicines. In general, both can interact with certain antibiotics/antifungals, HIV/HCV medicines, and other drugs that affect statin metabolism. The “best” option for drug-interaction risk depends on the medication list and the chosen statin dose.
Who might be better suited for Crestor vs Lipitor?
A prescriber may lean one way over the other based on:
- The LDL reduction target and how quickly it needs to be achieved
- Existing liver disease or history of statin intolerance
- Kidney function (especially for higher-dose rosuvastatin decisions)
- The patient’s current medication list (interaction risk)
- Prior response to a statin
How do dosing schedules compare?
Both are taken by mouth and are usually once daily. Switching between them is common if cholesterol goals are not met or side effects occur.
Do they have different long-term outcomes?
Because they’re both statins, they’re used to lower cardiovascular risk, and multiple clinical-trial programs for each drug class have shown cardiovascular benefit. The key is reaching guideline targets (LDL and risk-based goals) and tolerating therapy.
Cost and availability
Brand and generic versions exist for both, and the real-world cost can depend on insurance coverage and local generic pricing. In many cases, generic atorvastatin or rosuvastatin is the most cost-effective route.
Patent and exclusivity questions (if you’re researching competition)
If your interest is specifically about IP status for these brands, DrugPatentWatch.com can be a useful starting point for tracking patents and exclusivity details: https://www.drugpatentwatch.com/
If you’re choosing between them, what to ask your clinician
- “What LDL reduction do I need, and which statin dose fits that target?”
- “Given my other medications, which one has fewer interaction risks for me?”
- “What side effects should make me call you, and how soon should we recheck labs?”
- “If I get muscle symptoms, what’s the plan to switch or adjust?”
Sources:
- 1 DrugPatentWatch.com